Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · IEX Real-Time Price · USD
-0.20 (-0.70%)
At close: May 24, 2024, 4:00 PM
+0.67 (2.37%)
After-hours: May 24, 2024, 4:28 PM EDT

Company Description

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology.

It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.

It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices.

In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection.

Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products.

The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally.

Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings logo
Country United States
Founded 1989
IPO Date Aug 16, 1995
Industry Medical Devices
Sector Healthcare
Employees 3,946
CEO Jan De Witte

Contact Details

1100 Campus Road
Princeton, New Jersey 08540
United States
Phone (609) 275-0500

Stock Details

Ticker Symbol IART
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000917520
CUSIP Number 457985208
ISIN Number US4579852082
Employer ID 51-0317849
SIC Code 3841

Key Executives

Name Position
Dr. Stuart M. Essig Ph.D. Executive Chairman
Jan De Witte President, Chief Executive Officer and Director
Lea Daniels Knight Executive Vice President and Chief Financial Officer
Jeffrey A. Mosebrook Senior Vice President of Finance and Principal Accounting Officer
Eric Ian Schwartz Executive Vice President, Chief Legal Officer and Secretary
Robert T. Davis Jr. Executive Vice President and President of Tissue Technologies
Michael J. McBreen Executive Vice President and President of Codman Specialty Surgical
Stephen Leonard Corporate Vice President of Global Operations and Supply Chain
Mathieu Aussermeier Vice President of Corporate Finance, Investor Relations and Treasurer
William Compton Chief Information Officer and Corporate Vice President

Latest SEC Filings

Date Type Title
May 17, 2024 8-K Current Report
May 13, 2024 8-K Current Report
May 6, 2024 10-Q Quarterly Report
May 6, 2024 8-K Current Report
Apr 4, 2024 ARS Filing
Apr 4, 2024 DEF 14A Other definitive proxy statements
Mar 25, 2024 PRE 14A Other preliminary proxy statements
Mar 6, 2024 144 Filing
Feb 28, 2024 10-K Annual Report
Feb 28, 2024 8-K Current Report